Patents by Inventor Dawn Parsell OTTO

Dawn Parsell OTTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986490
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: May 21, 2024
    Assignee: Renosis, Inc.
    Inventors: Gerrit Klaerner, Jerry M. Buysse, Jun Shao, Dawn Parsell Otto
  • Publication number: 20230031665
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.
    Type: Application
    Filed: February 23, 2022
    Publication date: February 2, 2023
    Inventors: Gerrit KLAERNER, Jerry M. BUYSSE, Jun SHAO, Dawn Parsell OTTO
  • Patent number: 11266684
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.
    Type: Grant
    Filed: November 3, 2018
    Date of Patent: March 8, 2022
    Assignee: Tricida, Inc.
    Inventors: Gerrit Klaerner, Jerry M. Buysse, Jun Shao, Dawn Parsell Otto
  • Publication number: 20210187011
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Application
    Filed: November 3, 2018
    Publication date: June 24, 2021
    Inventors: Gerrit KLAERNER, Jerry M. BUYSSE, Jun SHAO, Dawn Parsell OTTO
  • Publication number: 20210106611
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human. In certain embodiments, compositions for and methods of improving the quality of life and/or physical function score of such patients are also provided. In certain embodiments, compositions for and methods of slowing the progression of kidney disease in such patients are also provided.
    Type: Application
    Filed: December 3, 2020
    Publication date: April 15, 2021
    Inventors: Gerrit KLAERNER, Dawn Parsell OTTO, Yuri STASIV, Vandana MATHUR, Claire LOCKEY
  • Publication number: 20200306209
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human. In certain embodiments, compositions for and methods of improving the quality of life and/or physical function score of such patients are also provided. In certain embodiments, compositions for and methods of slowing the progression of kidney disease in such patients are also provided.
    Type: Application
    Filed: March 25, 2020
    Publication date: October 1, 2020
    Inventors: Gerrit KLAERNER, Dawn Parsell OTTO, Yuri STASIV, Vandana MATHUR, Claire LOCKEY
  • Publication number: 20200289551
    Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.
    Type: Application
    Filed: November 3, 2018
    Publication date: September 17, 2020
    Inventors: Gerrit KLAERNER, Jerry M. BUYSSE, Jun SHAO, Dawn Parsell OTTO